Pms54 - Cost-Effectiveness Analysis of Etanercept as First Line of Treatment in Colombian Patients With Psoriatic Arthritis

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1768
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Meta-Analysis of Efficacy of Etanercept for Treatment of Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cost Per Responder of Apremilast Versus Etanercept and Adalimumab in Patients With Active Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Meta-Analysis for Efficacy of Etanercept for Treatment of Psoriatic Arthritis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Etanercept and Adalimumab Treatment Patterns in Psoriatic Arthritis Patients Enrolled in a Commercial Health Plan

Advances in Therapy
MedicinePharmacology
2012English

Pcn89 - Cost –Effectiveness Analysis of Pertuzumab as First Line Neoadjuvant Treatment Option for Patients Her2 + Breast Cancer in Republic of Macedonia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Psy100 - Cost-Effectiveness Analysis of Second Line Treatment for Patients With Ulcerative Colitis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

SAT0193 Early Discontinuation of First Line Biological Treatment With Etanercept in Patients With Rheumatoid Arthritis: Results From the Italian Gisea Registry

2018English

Cost-Effectiveness Analysis of Tocilizumab Subcutaneouscombotherapy First Line for the Management of Rheumatoid Arthritis in Greece

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pms38 - Cost Effectiveness Analysis of Secukinumab Versus Ustekinumab for the Treatment of Psoriatic Arthritis in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy